Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications

Fibrosing interstitial lung disease (ILD) is one of the most important causes of morbidity and mortality in patients with connective tissue diseases (CTDs), which include systemic sclerosis, rheumatoid arthritis, Sjögren’s syndrome, idiopathic inflammatory myositis and systemic lupus erythematosus....

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Drugs Context
Auteurs principaux: Erre, Gian Luca, Sebastiani, Marco, Manfredi, Andreina, Gerratana, Elisabetta, Atzeni, Fabiola, Passiu, Giuseppe, Mangoni, Arduino A
Format: Artigo
Langue:Inglês
Publié: BioExcel Publishing Ltd 2021
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813437/
https://ncbi.nlm.nih.gov/pubmed/33505482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.2020-8-6
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires